TCF7L2 rs79059780: Understanding Your Genetic Risk Marker
The rs79059780 variant is a genetic marker located within the TCF7L2 gene, which is widely recognized as one of the most significant genetic risk factors for type 2 diabetes. Research indicates that this variant is associated with changes in how the body regulates insulin secretion and glucose metabolism.
What each genotype means
Typical diabetes risk
You carry two copies of the common C allele at this locus. Research indicates that this genotype is not associated with increased susceptibility to impaired insulin secretion or type 2 diabetes. Your genetic background at this specific marker corresponds to baseline population risk.
Carried by approximately 50% to 60% of individuals of European and South Asian descent, and over 90% of individuals of East Asian ancestry.
Moderately elevated diabetes risk
You carry one copy of the T risk allele, which is in strong linkage disequilibrium with rs7903146 in the TCF7L2 gene. Published studies link the T allele to modest reductions in beta-cell insulin secretion and a moderately increased relative risk of developing type 2 diabetes. Lifestyle factors such as diet and physical activity remain powerful influences on your overall metabolic health.
Carried by approximately 35% to 42% of people of European and South Asian ancestry, but seen in less than 10% of East Asian populations.
Elevated diabetes risk
You carry two copies of the T risk allele linked to the well-known TCF7L2 diabetes risk haplotype. Statistical associations in population studies show that TT homozygotes have the highest relative risk within this locus for reduced insulin secretion and type 2 diabetes. This genetic finding indicates an increased statistical susceptibility rather than a medical diagnosis, and healthy lifestyle habits play a key role in metabolic outcomes.
Carried by roughly 5% to 10% of individuals of European and South Asian ancestry, and is rare (under 1%) in East Asian populations.
What is the rs79059780 Variant?
The rs79059780 variant is a single nucleotide polymorphism (SNP) situated within the TCF7L2 (Transcription Factor 7-Like 2) gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific marker is located in a region of the genome that has been extensively studied due to its strong statistical association with metabolic health. When researchers identify such variants, they are looking for correlations between specific DNA letters and observable traits or disease risks within large populations. It is important to note that while this variant is a well-established marker, it does not function in isolation; rather, it is part of a complex interplay of genetic, environmental, and lifestyle factors that influence an individual's health profile.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for making a protein that acts as a transcription factor, which helps control the activity of other genes. This protein plays a critical role in the Wnt signaling pathway, a system involved in various developmental processes, including the maintenance and function of pancreatic beta cells. Beta cells are responsible for producing and secreting insulin, the hormone that regulates blood glucose levels. Research suggests that variations in TCF7L2 can influence the expression of this gene in pancreatic islets, potentially impairing the body's ability to secrete insulin in response to glucose. By affecting the enteroinsular axis—the communication between the gut and the pancreas—the gene influences how the body manages blood sugar, making it a central focus in diabetes research.
Research and Evidence Strength
The association between TCF7L2 variants and type 2 diabetes is considered strong and has been replicated across multiple ethnic groups in numerous large-scale studies. Genomic linkage studies and meta-analyses have consistently identified this locus as a primary contributor to diabetes susceptibility. Scientific evidence suggests that the risk-associated alleles are linked to impaired insulin secretion rather than insulin resistance. While the statistical association is robust, it is essential to understand that this is a risk factor, not a deterministic cause. Having a specific genotype does not guarantee the development of a condition, nor does the absence of it provide immunity. The impact of these variants can be modified by lifestyle factors, such as diet and physical activity, which remain fundamental to metabolic health management.
What You Can Do With This Information
Understanding your genetic markers can be an educational tool for personal health awareness, but it should not be used for self-diagnosis or to make medical decisions. If you have concerns about your risk for type 2 diabetes, the most effective approach is to consult with a healthcare professional. They can evaluate your overall health, including family history, blood glucose levels, and lifestyle factors, to provide personalized guidance. Genetic information is only one piece of a much larger puzzle. If you are currently taking medication for blood sugar management, never alter your dosage or treatment plan based on genetic test results without first discussing it with your clinician or pharmacist. Focus on evidence-based lifestyle modifications, such as maintaining a balanced diet and regular exercise, which are proven to support metabolic health regardless of your genetic background.
How common is this variant?
The frequency of the risk-associated alleles in the TCF7L2 gene varies significantly by ancestry, but they are common across many global populations.
Frequently asked questions
Does having the TCF7L2 risk variant mean I will get diabetes?
No, having a risk variant does not mean you will develop diabetes. It simply means that, statistically, you may have a higher susceptibility, which can be influenced by many other genetic and environmental factors.
Can I change my genetic risk for diabetes?
You cannot change your DNA, but you can influence how your genes affect your health through lifestyle choices. Diet, exercise, and weight management are powerful tools that can help mitigate risk regardless of your genetic profile.
Should I get tested for TCF7L2 variants?
Genetic testing for common variants is generally not used for routine clinical diagnosis of diabetes. If you are concerned about your risk, speak with your doctor about standard clinical screenings like fasting glucose or HbA1c tests.
How does TCF7L2 affect insulin?
Research suggests that certain variants in TCF7L2 may impair the function of pancreatic beta cells, leading to reduced insulin secretion in response to glucose. This affects how effectively the body can lower blood sugar levels after eating.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs79059780?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.
This variant is one of the strongest genetic risk factors for Type 2 diabetes, affecting insulin secretion.